戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Pasteur Institute of Bangui, Africa CDC, AFROSCREEN, WHO
2                                              Pasteur's early approaches to vaccine development, atten
3 eld deployment, requiring little more than a Pasteur pipette and not being affected by dilution facto
4                       The Crabtree index and Pasteur index quantify the responses of oxidative and gl
5 lly characterized from the Ames, Sterne, and Pasteur strains of B. anthracis.
6 DGA capsule from the surface of B. anthracis Pasteur within 5 min.
7 ation that all life comes from other life-as Pasteur put it, omne vivum ex vivo.
8 ardly have been imagined by pioneers such as Pasteur, Escherich and Koch.
9     A recombinant vaccine containing Aventis Pasteur's canarypox vector (ALVAC)-HIV and gp120 alum de
10 nt primary vaccine trials of diluted Aventis Pasteur smallpox vaccine (APSV) demonstrated that immuni
11 cinated with a 1 : 5 dilution of the Aventis Pasteur smallpox vaccine.
12 ical trials of the smallpox vaccine (Aventis Pasteur) were conducted in healthy, vaccinia virus-naive
13 week after primary immunization with Aventis Pasteur smallpox vaccine.
14                                          BCG Pasteur had intermediate effects, and BCG Montreal was t
15 previously sequenced strains (AF2122/97, BCG Pasteur, H37Rv, and CDC1551) into 5 major "SNP cluster g
16 ectively 59% and 49% of ORFs of M. bovis BCG Pasteur and M. smegmatis mc(2) 155.
17 two species; namely, Mycobacterium bovis BCG Pasteur and Mycobacterium smegmatis mc(2) 155.
18 odel compared with subcutaneous M. bovis BCG Pasteur vaccination.
19 8(PE_PGRS)) found in Mycobacterium bovis BCG Pasteur, which is the BCG homologue of the M. tuberculos
20 red to that provided by a single dose of BCG Pasteur.
21 rom substrains derived from the original BCG Pasteur strain after 1925.
22 loss can also reduce the efficacy of the BCG Pasteur vaccine.
23 ciently to distant organs, compared with BCG Pasteur and BCG Montreal.
24  and M. bovis bacillus Calmette-Guerin (BCG) Pasteur in vivo and in vitro.
25 nel, M. bovis bacillus Calmette-Guerin (BCG) Pasteur, and M. bovis BCG Montreal were compared.
26 iveness studies (assessing the Behringwerke, Pasteur/Merieux, and SmithKline Beecham formulations) yi
27 e greatest stimulatory capacity, followed by Pasteur 1173 and then Danish 1331.
28 with the International Spoligotype database (Pasteur Institute, Pointe a Pitre, Guadeloupe) demonstra
29 oxo-IgG 2.0 and Toxo-IgM, Sanofi Diagnostics Pasteur Platelia Toxo IgG and Toxo IgM, and bioMerieux V
30  85.6%, respectively; and Sanofi Diagnostics Pasteur Platelia Toxo IgM, 100 and 96.8%, respectively.
31 latex agglutination (LA) (Sanofi Diagnostics Pasteur, Guildford, Surrey, United Kingdom) by using 406
32 iods from freshwater Synechococcus elongatus Pasteur Culture Collection (PCC) 7942, with 6-methyl-5-h
33 ealed surge isolates belonged to an emergent Pasteur scheme sequence type 499 and comprised multiple
34 cterium bovis BCG (bacillus Calmette-Guerin, Pasteur).
35                   Building on the historical Pasteur-Bechamp debates on the role of the "microbe" vs
36 effects such as acidosis caused by a hypoxic Pasteur effect (instead of low O(2) by itself) are neces
37                          We should follow in Pasteur's footsteps by using basic research to develop b
38                                     Institut Pasteur in Cambodia, Institut Pasteur Paris, National In
39                                     Institut Pasteur, Institut Pasteur International Network, Fondati
40 atabases from Oxford University and Institut Pasteur, import genomes from public repositories, and ad
41      Meningitis Vaccine Project and Institut Pasteur.
42       Institut Pasteur in Cambodia, Institut Pasteur Paris, National Institutes of Health, WHO, Agenc
43 alitides, 1.82% (-2.75 to 5.39) for Institut Pasteur Dakar, and 0.0% (-3.32 to 3.29) for Sanofi Paste
44                   Institut Pasteur, Institut Pasteur International Network, Fondation Merieux, Aviesa
45 , John Lennon Memorial Scholarship, Institut Pasteur, Sante publique France, Fondation Le Roch-Les Mo
46 ion to receive vaccination with the Institut Pasteur de Dakar 17D-204 yellow fever vaccine at a stand
47 cases were detected in Conakry, the Institut Pasteur of Dakar, Senegal, deployed a mobile laboratory
48 an Type Culture Collection, and the Institut Pasteur, offer enhanced insight since they typically spa
49 Pasteur Dakar standard dose, 120 to Institut Pasteur Dakar fractional dose, 120 to Sanofi Pasteur sta
50 ephalitides fractional dose, 120 to Institut Pasteur Dakar standard dose, 120 to Institut Pasteur Dak
51 ogenicity of the ID 2-site, 3-visit Institut Pasteur Cambodge (IPC) PEP regimen to the IM 1-site, 4-v
52 Public Health Laboratories (Yemen), Institut Pasteur, and the French Government Investissement d'Aven
53 ain number ATCC 700975) and in the Institute Pasteur collection (assigned strain number CIP 107346).
54                        The Chair introduced "Pasteur's Quadrant" as a potentially useful paradigm for
55                                Less known is Pasteur's vision on infection prevention and control (IP
56 f M. bovis BCG (Copenhagen, Glaxo, Japanese, Pasteur, and Tice), and two strains of virulent Mycobact
57                                        Louis Pasteur has long been heralded as one of the fathers of
58                                        Louis Pasteur once famously said 'in the fields of observation
59 ude nerve tissue vaccines developed by Louis Pasteur and his colleagues in 1885.
60 sed in vertical programmes inspired by Louis Pasteur, while vying with early private humanitarian act
61 cose metabolism was first described by Louis Pasteur.
62          Medical officers incorporated Louis Pasteur's discoveries into their understanding of microo
63 ryday life, years of establishing what Louis Pasteur called "the prepared mind," working with mentors
64 obiota has been recognized since the days of Pasteur.
65 in nature has been ongoing since the time of Pasteur.
66                                We focused on Pasteur's far-sighted conceptualisation of the hospital
67  (University Hospital, Military Hospital, or Pasteur Clinic).
68                 In this Review, we revisited Pasteur's pioneering works to assess progress and challe
69                                       Sanofi Pasteur has developed a chimeric yellow fever-dengue, li
70                                       Sanofi Pasteur has developed a tetravalent dengue vaccine (TDV)
71                                       Sanofi Pasteur's TDV was well tolerated and induced full seroco
72 week 0; yellow fever vaccine (YF-17D; Sanofi Pasteur, Lyon, France); live oral typhoid vaccine (Ty21a
73 eceived yellow fever vaccine (YF-17D; Sanofi Pasteur, Lyon, France; 0.5 mL intramuscularly, left uppe
74  or the 9-valent vaccine (Gardasil-9, Sanofi Pasteur MSD, Lyon).
75  or the 9-valent vaccine (Gardasil 9, Sanofi Pasteur MSD, Lyon, France).
76  dilution of Wyeth Dryvax vaccine and Sanofi Pasteur smallpox vaccine, given that the resulting morbi
77 f Allergy and Infectious Diseases and Sanofi Pasteur.
78  5 mug protein-based Vidprevtyn Beta (Sanofi Pasteur, Lyon, France) were received according to the na
79 onducted in Asia and Latin America by Sanofi Pasteur has constituted an important step.
80 , India) at week 0; the yellow fever (Sanofi Pasteur, Lyon, France), oral typhoid (PaxVax, London, UK
81 eated influenza vaccination (Flublok; Sanofi Pasteur) in adults 18-45 years of age.
82 r Dakar, and 0.0% (-3.32 to 3.29) for Sanofi Pasteur.
83  mL intramuscular; both vaccines from Sanofi Pasteur) were administered.
84 a live-virus tetravalent vaccine from Sanofi Pasteur, was recently approved for human clinical use, a
85                               Funding:Sanofi Pasteur.
86 ic or monomeric rHA1 or with SU-H5N1 (Sanofi Pasteur) emulsified with Titermax adjuvant and were chal
87 th DTaP-IPV-HB-PRP~T vaccine (Hexyon; Sanofi Pasteur) and blood collected before and 1 month after pr
88 uted Dryvax vaccine or 1 of 2 lots of Sanofi Pasteur smallpox vaccine and were evaluated for vaccinat
89 A approval and ACIP recommendation of Sanofi Pasteur's Dengvaxia vaccine, highlighting the need for a
90 alent HBV vaccine (Euvax-B Pediatric: Sanofi Pasteur, Seoul, South Korea; 0.5 mL) within 24 h of life
91 d part of the review, we focus on the Sanofi Pasteur dengue vaccine candidate, describing the steps f
92 ofi Pasteur standard dose, and 120 to Sanofi Pasteur fractional dose).
93 Pasteur Dakar fractional dose, 120 to Sanofi Pasteur standard dose, and 120 to Sanofi Pasteur fractio
94 ficant morbidity when used undiluted; Sanofi Pasteur, Inc., later identified approximately 85 million
95                                       Sanofi-Pasteur's chimeric yellow fever tetravalent dengue vacci
96                                       Sanofi-Pasteur's CYD-TDV is the only licensed dengue vaccine.
97 onent GlaxoSmithKline and 5-component Sanofi-Pasteur formulations) yielded an overall aP vaccine effi
98 e, Buruli ulcer Groningen Foundation, Sanofi-Pasteur, and BuruliVac.
99                                   Ever since Pasteur noticed that tartrate crystals exist in two non-
100 entral focus of the molecular sciences since Pasteur, its province has previously been restricted to
101 metry in crystal form has been studied since Pasteur correlated macroscopic and microscopic chirality
102 tative cellulose synthases from Anabaena sp. Pasteur Culture Collection 7120 and N. punctiforme Ameri
103 tative cellulose synthases from Anabaena sp. Pasteur Culture Collection 7120 and Nostoc punctiforme A
104  negative control over glycolysis (-26%; the Pasteur effect).
105  Widal test was run at the hospitals and the Pasteur Institute.
106 sted for antimicrobial susceptibility at the Pasteur Institute in Ho Chi Minh City.
107 interested in antibodies as a postdoc at the Pasteur Institute in Paris and a proponent of the antige
108 s ago, when I spent a sabbatical year at The Pasteur Institute in Paris.
109 I was fortunate to meet Jacques Monod at the Pasteur Institute, and this became a turning point in my
110 ls and 61% and 100% for Widal testing at the Pasteur Institute.
111 , they are classified as separate STs by the Pasteur Institute MLST system, and an ST131 PCR method t
112 rmanent respiratory defect that bypassed the Pasteur effect (i.e., the inhibition of anaerobic fermen
113  in both melanocytes and melanoma cells (the Pasteur effect).
114 ein kinase cascade, that can account for the Pasteur effect in ischaemic heart muscle.
115  from Canada, two reference strains from the Pasteur Institute collection (Paris, France), and two co
116  that both R3230Ac and FSA tumors retain the Pasteur effect, i.e., hypoxia triggers increased glycoly

 
Page Top